Zura Bio Limited
ZURA
$5.72
-$0.41-6.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.59% | -41.04% | 4.79% | -12.80% | 8.31% |
| Total Depreciation and Amortization | 0.00% | 6.67% | 7.14% | 27.27% | 22.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.09% | 308.18% | -200.96% | -36.82% | 2.92% |
| Change in Net Operating Assets | 1,242.07% | 110.00% | -1,475.63% | 105.15% | -241.49% |
| Cash from Operations | -10.45% | 15.06% | -44.25% | 3.66% | -44.90% |
| Capital Expenditure | -84.62% | 23.53% | 46.88% | -113.33% | 69.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -84.62% | 23.53% | 46.88% | -113.33% | 69.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 775,635.29% | 466.67% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 144.89% | 144.34% | -- | -- | 100.00% |
| Cash from Financing | -99.66% | 1,947.20% | -243,933.33% | 108.82% | -100.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.61% | 492.39% | -91.37% | 3.77% | -171.19% |